These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9255595)

  • 1. Pharmacokinetics and muscle histopathology of intramuscular valproate.
    Gallo BV; Slater JD; Toledo C; DeToledo J; Ramsay RE
    Epilepsy Res; 1997 Jul; 28(1):11-5. PubMed ID: 9255595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of infusion duration on valproate pharmacokinetics.
    Hussein Z; Patterson KJ; Lamm JE; Cavanaugh JH; Granneman GR
    Biopharm Drug Dispos; 1993 Jul; 14(5):389-99. PubMed ID: 8218957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation.
    Hussein Z; Mukherjee D; Lamm J; Cavanaugh JH; Granneman GR
    J Clin Pharmacol; 1994 Jul; 34(7):754-9. PubMed ID: 7929870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous valproate dosing in neonates.
    Alfonso I; Alvarez LA; Gilman J; Dunoyer C; Yelin K; Papazian O
    J Child Neurol; 2000 Dec; 15(12):827-9. PubMed ID: 11198504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of administration route on valproate pharmacokinetics in the rabbit.
    Bourin M; Guenzet J; Thomare P; Kergueris MF; Ortega A; Larousse C
    Fundam Clin Pharmacol; 1991; 5(4):331-9. PubMed ID: 1916614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid infusion of sodium valproate in acutely ill children.
    Birnbaum AK; Kriel RL; Norberg SK; Wical BS; Le DN; Leppik IE; Cloyd JC
    Pediatr Neurol; 2003 Apr; 28(4):300-3. PubMed ID: 12849885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
    Edwards KR; Norton J; Behnke M
    Headache; 2001; 41(10):976-80. PubMed ID: 11903525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE; Fu KP; Neu HC
    Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of valpromide in dogs after various modes of administration.
    Bialer M; Rubinstein A
    Biopharm Drug Dispos; 1984; 5(2):177-83. PubMed ID: 6430363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs.
    Isert D; Klesel N; Limbert M; Markus A; Seibert G; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():31-7. PubMed ID: 1601754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic analysis of ester prodrugs of valproic acid.
    Hadad S; Vree TB; van der Kleijn E; Bialer M
    J Pharm Sci; 1992 Oct; 81(10):1047-50. PubMed ID: 1432619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of pethidine administered intramuscularly and intravenously to dogs over 10 years old.
    Waterman AE; Kalthum W
    Res Vet Sci; 1990 Mar; 48(2):245-8. PubMed ID: 2333432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent pharmacokinetics of valproate in guinea pigs of different ages.
    Yu HY; Shen YZ; Sugiyama Y; Hanano M
    Epilepsia; 1987; 28(6):680-7. PubMed ID: 3121286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous valproate loading in acutely manic and depressed bipolar I patients.
    Grunze H; Erfurth A; Amann B; Giupponi G; Kammerer C; Walden J
    J Clin Psychopharmacol; 1999 Aug; 19(4):303-9. PubMed ID: 10440456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous valproate associated with circulatory collapse.
    Kumar P; Vallis CJ; Hall CM
    Ann Pharmacother; 2003 Dec; 37(12):1797-9. PubMed ID: 14632603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sodium valproate in dog and mouse.
    Löscher W; Esenwein H
    Arzneimittelforschung; 1978; 28(5):782-7. PubMed ID: 373773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of intravenous and intramuscular methohexitone in dogs.
    Pinaud M; Meignier M; Kergueris MF; Le Normand Y; Lasserre MP; Souron R; Larousse C
    Eur J Anaesthesiol; 1984 Mar; 1(1):55-62. PubMed ID: 6536507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
    Sekhar S; Kalra B; Mendhekar DN; Tekur U
    J Clin Pharmacol; 2010 Jun; 50(6):688-92. PubMed ID: 20075184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients.
    Venkataraman V; Wheless JW
    Epilepsy Res; 1999 Jun; 35(2):147-53. PubMed ID: 10372567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.